London
· Delayed Price · Currency is GBP · Price in USD Novavax Company Description
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases.
It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response.
It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination.
The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications.
It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
| Country | United States |
| Founded | 1987 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 1,543 |
| CEO | John Jacobs |
Contact Details
Address: 700 Quince Orchard Road Gaithersburg, Delaware 20878 United States | |
| Phone | 240 268 2000 |
| Website | global.novavax.com |
Stock Details
| Ticker Symbol | 0A3S |
| Exchange | London Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| John Charles Jacobs M.B.A. | President, Chief Executive Officer and Director |
| John Joseph Trizzino B.S., M.B.A. | President and Chief Operating Officer |
| James Patrick Kelly C.F.A. | Executive Vice President, Chief Financial Officer and Treasurer |
| Mark Casey | Executive Vice President, Chief Legal Officer and Corporate Secretary |
| Richard P. Crowley | Executive Vice President and Chief Operating Officer |
| Troy Morgan Esq., J.D. | Senior Vice President, Deputy General Counsel and Chief Compliance Officer |
| Erika S. Trahan | Associate Director of Investor and Public Relations |
| Ian J. Watkins | Executive Vice President and Chief Human Resources Officer |
| Silvia Taylor M.B.A. | Executive Vice President and Chief Corporate Affairs and Advocacy Officer |
| Dr. Robert Walker M.D. | Senior Vice President and Chief Medical Officer |